FdaApplication
BLA 761286
Identifiers
- fda_app_no: BLA761286
Properties
| Property | Value |
|---|---|
| applicant_name | UCB, Inc. |
| application_type | BLA |
| approval_date | 2023-06-26 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RYSTIGGO | ROZANOLIXIZUMAB-NOLI | 280MG/2ML (140MG/ML) | Injection |
| RYSTIGGO | — | 560MG/4ML (140MG/ML) | Injection |
| RYSTIGGO | — | 840MG/6ML (140MG/ML) | Injection |
| RYSTIGGO | — | 420MG/3ML (140MG/ML) | Injection |
4 products